tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ZYME is currently covered by 8 analysts with an average price target of $42. This is a potential upside of $16.09 (43.3%) from yesterday's end of day stock price of $29.31.
Zymeworks Common Stock's activity chart (see below) currently has 106 price targets and 108 ratings on display. The stock rating distribution of ZYME is 78.57% BUY and 21.43% HOLD.
Analysts average stock forecasts to be materialized ratio is 62.82% with an average time for these price targets to be met of 186.65 days.
Highest price target for ZYME is $58, Lowest price target is $23, average price target is $42.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 25-Aug-2026. First documented stock forecast 23-May-2017.
Currently out of the existing stock ratings of ZYME, 22 are a BUY (78.57%), 6 are a HOLD (21.43%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Aug-2018
$38
$8.69 (29.65%)
$35
Buy Since 17-Nov-2025
$55
$25.69 (87.65%)
$51
Buy Since 09-Oct-2025
$44
$14.69 (50.12%)
$40
Buy Since 07-May-2026
$40
$10.69 (36.47%)
$37
Buy Since 30-Aug-2019
$47
$22.85 (94.62%)
$40
What is ZYME (Zymeworks Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on ZYME (Zymeworks Common Stock) with a proven track record?
Which analyst has the most public recommendations on ZYME (Zymeworks Common Stock)?
Which analyst is the currently most bullish on ZYME (Zymeworks Common Stock)?
Which analyst is the currently most reserved on ZYME (Zymeworks Common Stock)?
